SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+50.3%
5Y CAGR+25.0%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+50.3%/yr
Annual compound
5Y CAGR
+25.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $172.81M | +291.0% |
| 2024 | $44.20M | -47.3% |
| 2023 | $83.94M | +64.9% |
| 2022 | $50.90M | -37.3% |
| 2021 | $81.14M | +43.5% |
| 2020 | $56.54M | +214.0% |
| 2019 | $18.00M | - |